Zobrazeno 1 - 10 of 39 pro vyhledávání: '"Dapena, JL"'
1
Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available
Autor: Rosales A, Alvaro Madrid Aris, Muñoz M, Dapena JL, Ariceta G
Publikováno v: Frontiers in pediatrics
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Background: High dose methotrexate (HDMTX) is used for the treatment of pediatric hemato-oncological diseases. HDMTX can induce acute kidney injury in cases of delayed elimination. The use of leucovorin remains the most effective rescue action. Furth
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3965b569faf28e554b3e194c989e2b92
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20078
Zobrazit plný text záznamu
2
Protocol for the study and treatment of primary immune thrombocytopenia: ITP-2018
Autor: Monteagudo, E, Astigarraga, I, Cervera, A, Dasi, MA, Sastre, A, Berrueco, R, Dapena, JL, PTI Working Grp, Spanish Soc Paediat Haematol
Publikováno v: ANALES DE PEDIATRIA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Primary immune thrombocytopenia, formerly known as immune thrombocytopenic purpura, is a disease for which the clinical and therapeutic management has always been controversial. The ITP working group of the Spanish Society of Paediatric Haematology a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::aaf7b02731fb8ac8d66e0772ca931097
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11283
Zobrazit plný text záznamu
3
Protocolo de estudio y tratamiento de la trombocitopenia inmune primaria: PTI-2018
Autor: Monteagudo E, Astigarraga I, Cervera Á, Dasí MA, Sastre A, Berrueco R, Dapena JL, en representación del Grupo de Trabajo de la PTI de la Sociedad Española de Hema
Publikováno v: ANALES DE PEDIATRIA
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Primary immune thrombocytopenia, formerly known as immune thrombocytopenic purpura, is a disease for which the clinical and therapeutic management has always been controversial. The ITP working group of the Spanish Society of Paediatric Haematology a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::1eaf7ad080f086b96a8c8099ebef3bdb
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=16341
Zobrazit plný text záznamu
4
Osmotic gradient ektacytometry: A valuable screening test for hereditary spherocytosis and other red blood cell membrane disorders
Autor: Llaudet-Planas, E, Vives-Corrons, JL, Rizzuto, V, Gomez-Ramirez, P, Navarro, JS, Sibina, MTC, Garcia-Bernal, M, Llobet, AR, Badell, I, Velasco-Puyo, P, Dapena, JL, Manu-Pereira, MM
Publikováno v: International Journal of Laboratory Hematology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
IntroductionNew generation osmotic gradient ektacytometry has become a powerful procedure for measuring red blood cell deformability and therefore for the diagnosis of red blood cell membrane disorders. In this study, we aim to provide further suppor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::d75378bd5006e529f59ba142bb2bd4ae
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3940
Zobrazit plný text záznamu
5
Controversias en el tratamiento de la trombocitopenia inmune pediátrica
Autor: Berrueco R, Dapena JL, Sebastián E, Sastre A
Publikováno v: ANALES DE PEDIATRIA
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Immune thrombocytopenia (ITP) is a relatively common disorder in childhood. Although it usually achieves spontaneous remission at this age, the management of persistent or chronic ITP in children is still controversial. The aim of this article is to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2c0a84aaef266d163f70090da083bbd1
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14702
Zobrazit plný text záznamu
7
Asparaginase use for the treatment of acute lymphoblastic leukemia
Autor: Barba P, Dapena JL, Montesinos P, Rives-Sola S
Publikováno v: MEDICINA CLINICA
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bcd22c1635450c428a265cb4d8720aa2
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=10712
Zobrazit plný text záznamu
9
Akademický článek
Secondary haematological dysplasia after CAR-T-cell therapy for acute lymphoblastic leukaemia in children.
Autor: Theron A; Leukemia and Lymphoma Department, CAR-T-Cell Unit, Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu de Barcelona, University of Barcelona, Esplugues de Llobregat, Spain.; Department of Pediatric Oncology and Hematology, Hôpital Arnaud de Villeneuve, Univ Montpellier, CHU Montpellier, Montpellier, France., Alonso-Saladrigues A; Leukemia and Lymphoma Department, CAR-T-Cell Unit, Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu de Barcelona, University of Barcelona, Esplugues de Llobregat, Spain.; Faculty of Medicine PhD Student, University of Barcelona, Barcelona, Spain.; Developmental Tumors Biology Group, Leukemia, and Other Pediatric Hemopathies, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain., Dapena JL; Leukemia and Lymphoma Department, CAR-T-Cell Unit, Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu de Barcelona, University of Barcelona, Esplugues de Llobregat, Spain.; Developmental Tumors Biology Group, Leukemia, and Other Pediatric Hemopathies, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain., López-Duarte M; Pediatric Hematology Unit, Hematology Department, Hospital de Valdecilla, Santander, Spain., Diaz de Heredia C; Pediatric Hematology and Oncology Department, Hospital Universitari Vall d'Hebron, and Vall d'Hebron Institut of Research (VHIR), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Verdú-Amorós J; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Department of Pediatric Hematology and Oncology, Hospital Clínico Universitario, Biomedical Research Institute (INCLIVA), Valencia, Spain., Sarrate E; Hematology Laboratory, Hospital Sant Joan de Déu de Barcelona, Esplugues de Llobregat, Spain., Esperanza-Cebollada E; Developmental Tumors Biology Group, Leukemia, and Other Pediatric Hemopathies, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain., Cuatrecasas E; Cytogenetics Laboratory, Genetics Medicine Section, Hospital Sant Joan de Déu de Barcelona, Esplugues de Llobregat, Spain., Andreu S; Cytogenetics Laboratory, Genetics Medicine Section, Hospital Sant Joan de Déu de Barcelona, Esplugues de Llobregat, Spain., Conde N; Leukemia and Lymphoma Department, CAR-T-Cell Unit, Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu de Barcelona, University of Barcelona, Esplugues de Llobregat, Spain., Sanchez-Sierra N; Leukemia and Lymphoma Department, CAR-T-Cell Unit, Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu de Barcelona, University of Barcelona, Esplugues de Llobregat, Spain., Isola I; Developmental Tumors Biology Group, Leukemia, and Other Pediatric Hemopathies, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Hematology Laboratory, Hospital Sant Joan de Déu de Barcelona, Esplugues de Llobregat, Spain., Camós M; Developmental Tumors Biology Group, Leukemia, and Other Pediatric Hemopathies, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Hematology Laboratory, Hospital Sant Joan de Déu de Barcelona, Esplugues de Llobregat, Spain., Torrebadell M; Developmental Tumors Biology Group, Leukemia, and Other Pediatric Hemopathies, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Hematology Laboratory, Hospital Sant Joan de Déu de Barcelona, Esplugues de Llobregat, Spain., Rives S; Leukemia and Lymphoma Department, CAR-T-Cell Unit, Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu de Barcelona, University of Barcelona, Esplugues de Llobregat, Spain.; Developmental Tumors Biology Group, Leukemia, and Other Pediatric Hemopathies, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Català A; Leukemia and Lymphoma Department, CAR-T-Cell Unit, Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu de Barcelona, University of Barcelona, Esplugues de Llobregat, Spain.; Developmental Tumors Biology Group, Leukemia, and Other Pediatric Hemopathies, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v: British journal of haematology [Br J Haematol] 2024 Oct 28. Date of Electronic Publication: 2024 Oct 28.
Zobrazit plný text záznamu
10
Akademický článek
ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer.
Autor: Juan-Ribelles A; Pediatric Oncology and Hematology Unit, Hospital Universitari y Politécnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain., Bautista F; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Cañete A; Pediatric Oncology and Hematology Unit, Hospital Universitari y Politécnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain., Rubio-San-Simón A; Pediatric Oncology, Hematology and Stem Cell Transplant Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Alonso-Saladrigues A; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Institut de Recerca San Joan de Déu (IRSJD), Barcelona, Spain., Hladun R; Division of Pediatric Hematology and Oncology, Vall d'Hebron Comprehensive Cancer Center, Hospital Universitari Vall d'Hebrón, Passeig Vall d'Hebron 119, 08172, Barcelona, Spain., Rives S; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Institut de Recerca San Joan de Déu (IRSJD), Barcelona, Spain., Dapena JL; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Institut de Recerca San Joan de Déu (IRSJD), Barcelona, Spain., Fernández JM; Pediatric Oncology and Hematology Unit, Hospital Universitari y Politécnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain., Lassaletta Á; Pediatric Oncology, Hematology and Stem Cell Transplant Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Cruz O; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Institut de Recerca San Joan de Déu (IRSJD), Barcelona, Spain., Ramírez-Villar G; Department of Pediatric Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain., Fuster JL; Hospital Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., de Heredia CD; Division of Pediatric Hematology and Oncology, Vall d'Hebron Comprehensive Cancer Center, Hospital Universitari Vall d'Hebrón, Passeig Vall d'Hebron 119, 08172, Barcelona, Spain., García-Ariza M; Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, Osakidetza, Barakaldo, Bizkaia, Spain., Quiroga E; Department of Pediatric Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain., Del Mar Andrés M; Pediatric Oncology and Hematology Unit, Hospital Universitari y Politécnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain., Verdú-Amorós J; INCLIVA - Biomedical Research Institute, Hospital Clínico Universitario, Valencia, Spain., Molinés A; Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Las Palmas, Spain., Herrero B; Pediatric Oncology, Hematology and Stem Cell Transplant Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., López M; Hematology Department, University Hospital Marqués de Valdecilla (IDIVAL), Santander, Spain., Márquez C; Department of Pediatric Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain., Toboso M; Pediatric Oncology and Hematology Unit, Hospital Universitari y Politécnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain., Lendínez F; Unidad de Oncohematologia Pediatrica. Hospital Infantil Universitario Torrecárdenas, Almeria, Spain., Sirvent JG; Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain., Tallón M; Hospital Alvaro Cunqueiro, Vigo, Spain., Rodríguez G; Sofpromed, CRO para ensayos clínicos en España, Palma de Mallorca, Spain., Acha T; Unidad de Oncología Pediátrica, Hospital Materno-Infantil Carlos Haya, Málaga, Spain., Moreno L; Division of Pediatric Hematology and Oncology, Vall d'Hebron Comprehensive Cancer Center, Hospital Universitari Vall d'Hebrón, Passeig Vall d'Hebron 119, 08172, Barcelona, Spain. lucas.moreno@vallhebron.cat., Fernández-Teijeiro A; Hospital Universitario Virgen Macarena, Seville, Spain.
Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Sep; Vol. 26 (9), pp. 2351-2359. Date of Electronic Publication: 2024 Apr 10.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje